128 related articles for article (PubMed ID: 11020348)
21. Gamma-irradiation enhances transgene expression in leukemic cells.
Vereecque R; Saudemont A; Wickham TJ; Gonzalez R; Hetuin D; Fenaux P; Quesnel B
Gene Ther; 2003 Feb; 10(3):227-33. PubMed ID: 12571630
[TBL] [Abstract][Full Text] [Related]
22. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
23. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
[TBL] [Abstract][Full Text] [Related]
24. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
25. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
26. Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
Deng W; Bivalacqua TJ; Chattergoon NN; Jeter JR; Kadowitz PJ
Stem Cells; 2004; 22(7):1279-91. PubMed ID: 15579646
[TBL] [Abstract][Full Text] [Related]
27. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
28. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
29. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
Cao B; Bruder J; Kovesdi I; Huard J
Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
[TBL] [Abstract][Full Text] [Related]
30. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral-mediated gene transfer to liver xenografts results in successful expression and protein production.
Drazan KE; Shen XD; Wu L; Jurim O; Busuttil RW; Shaked A
Transplant Proc; 1995 Feb; 27(1):331-2. PubMed ID: 7879020
[No Abstract] [Full Text] [Related]
33. Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain.
Zou L; Yotnda P; Zhao T; Yuan X; Long Y; Zhou H; Yang K
J Cereb Blood Flow Metab; 2002 Aug; 22(8):959-70. PubMed ID: 12172381
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues.
Gonzalez-Nicolini V; Sanchez-Bustamante CD; Hartenbach S; Fussenegger M
J Gene Med; 2006 Oct; 8(10):1208-22. PubMed ID: 16960915
[TBL] [Abstract][Full Text] [Related]
35. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors.
Kügler S; Meyn L; Holzmüller H; Gerhardt E; Isenmann S; Schulz JB; Bähr M
Mol Cell Neurosci; 2001 Jan; 17(1):78-96. PubMed ID: 11161471
[TBL] [Abstract][Full Text] [Related]
36. Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease.
Shen JS; Meng XL; Yokoo T; Sakurai K; Watabe K; Ohashi T; Eto Y
J Gene Med; 2005 May; 7(5):540-51. PubMed ID: 15685691
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
38. Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain.
Serguera C; Sarkis C; Ridet JL; Colin P; Moullier P; Mallet J
Mol Ther; 2001 Jun; 3(6):875-81. PubMed ID: 11407901
[TBL] [Abstract][Full Text] [Related]
39. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.
Zheng C; Baum BJ
Mol Ther; 2005 Sep; 12(3):528-36. PubMed ID: 16099414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
